MedTrace Logo

Risk Assessment Tool in Saudi Arabia

NCT02781116 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2016-05-24

No results posted yet for this study

Summary

This study will have great impact and influence in the medical setting as the targeted model that will be derived from this study will be the pioneer in our region. This model will be beneficial in identifying risk factors and its association with the Arab women population. Furthermore, it will bring chemotherapy prevention once the risk factors and the model are established. Risk factors maybe different from those identified in western women by Gail and IBIS Models

Conditions

Sponsors & Collaborators

  • National Guard Health Affairs

    lead OTHER_GOV

Principal Investigators

  • Omalkhair Abulkhair · Ministry of National Guard Health Affairs

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02781116 on ClinicalTrials.gov